In vitro antibacterial activity of cefiderocol against recent multidrug-resistant carbapenem-nonsusceptible Enterobacterales isolates-Reference-Cited by-同舟云学术

In vitro antibacterial activity of cefiderocol against recent multidrug-resistant carbapenem-nonsusceptible Enterobacterales isolates

Published:2022-05 Issue:1 Volume:103 Page:115651
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Zhang Qingyu^ORCID,Neidig Nicholas^ORCID,Chu Ting-Yu,Divoky Cameron,Carpenter Jessica,Lee-Hsiao Cristian^ORCID,Threatt Hillary,Sultana Rasheda^ORCID,Bush Karen^ORCID

Funder

Shionogi and Co Ltd

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference29 articles.

1. In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria;Ito;J Antimicrob Chemother,2016

2. In vitro antimicrobial activity of a siderophore cephalosporin, S-649266, against Enterobacteriaceae clinical isolates, including carbapenem-resistant strains;Kohira;Antimicrob Agents Chemother,2016

3. New perspectives on antimicrobial agents: cefiderocol;McCreary;Antimicrob Agents Chemother,2021

4. Siderophore cephalosporin cefiderocol utilizes ferric iron transporter systems for antibacterial activity against Pseudomonas aeruginosa;Ito;Antimicrob Agents Chemother,2016

5. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study)

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eravacycline: a comprehensive review of in vitro activity, clinical efficacy, and real-world applications;Expert Review of Anti-infective Therapy;2024-05-08

2. Emergence of a clinical Salmonella enterica serovar 1,4,[5], 12: i:-isolate, ST3606, in China with susceptibility decrease to ceftazidime-avibactam carrying a novel blaCTX-M-261 variant and a blaNDM-5;European Journal of Clinical Microbiology & Infectious Diseases;2024-02-22

3. Global prevalence of cefiderocol non-susceptibility in Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii, and Stenotrophomonas maltophilia: a systematic review and meta-analysis;Clinical Microbiology and Infection;2024-02

4. Global Resistance of Imipenem/Relebactam against Gram-Negative Bacilli: Systematic Review and Meta-Analysis;Current Therapeutic Research;2024

5. In Vitro Activity of Cefiderocol Compared to Other Antimicrobials against a Collection of Metallo-Beta-Lactamase-Producing Gram-Negative Bacilli from Southern Spain;Microbiology Spectrum;2023-06-15